Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Psoriasis (Auckland, N.Z.)|May 17, 2018
Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registryBjorn Gudbjornsson, Arni Jon Geirsson, Niels Steen Krogh
Rheumatology (Oxford, England)|March 11, 2022
Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone appAlexander G S Oldroyd, Niels Steen Krogh, William G Dixon, et al.
Seminars in Arthritis and Rheumatism|January 14, 2022
Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis - data from the Danish nationwide DANBIO registryAshish J Mathew, Bente Glintborg, Niels Steen Krogh, et al.
JMIR Formative Research|May 28, 2020
Reliability, Feasibility, and Patient Acceptance of an Electronic Version of a Multidimensional Health Assessment Questionnaire for Routine Rheumatology Care: Validation and Patient Preference StudyTheodore Pincus, Isabel Castrejon, Mariam Riad, et al.
Rheumatology (Oxford, England)|February 2, 2018
Physical activity behaviour in men with inflammatory joint disease: a cross-sectional register-based studyNanna Maria Hammer, Julie Midtgaard, Merete Lund Hetland, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registryBente Glintborg, Mikkel Ostergaard, Niels Steen Krogh, et al.
Clinical and Experimental Rheumatology|October 21, 2016
Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registryMerete L Hetland, Niels Steen Krogh, Kim Hørslev-Petersen, et al.
RMD Open|August 16, 2019
Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligibleOlafur Palsson, Thorvardur Jon Love, Anna Ingibjorg Gunnarsdottir, et al.
JMIR Mhealth and Uhealth|July 25, 2020
Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design ProcessAstrid Eliasen, Mikkel Kramme Abildtoft, Niels Steen Krogh, et al.
Vaccines|January 22, 2022
Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases-An Interim Report from a Danish Prospective Cohort StudyKaren Schreiber, Christine Graversgaard, Randi Petersen, et al.
Pageof 7